In the non-CKD group, plasma CTRP9 level was found to be an independent determinant of max-IMT (β = 0.128, p = 0.037) and mean-IMT (β = 0.124, p = 0.028) (Table 2). Here, C1QTNF9 is linked to chronic kidney disease.